Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New developments in topical estrogen therapy

R Jewelewicz1

  • 1Department of Obstetrics and Gynecology, Maimonides Medical Center, State University of New York Health Science Center at Brooklyn 11219, USA.

Fertility and Sterility
|January 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Induction of ovulation: current practice and prospects.

Bulletin of the New York Academy of Medicine·2009
Same author

Maternal arrhythmias of normal labor and delivery.

Gynecologic and obstetric investigation·2001
Same author

A controlled study for gender selection using swim-up separation.

Gynecologic and obstetric investigation·1999
Same author

Estrogens and Parkinson's disease.

Medical hypotheses·1994
Same author

Assisted reproduction in contemporary Jewish law and ethics.

Gynecologic and obstetric investigation·1994
Same author

Current concepts in estrogen replacement therapy in the menopause.

Fertility and sterility·1993
Same journal

Fresh vs. frozen donor oocytes: which strategy best serves patients in contemporary assisted reproductive technology?

Fertility and sterility·2026
Same journal

From fetal life to adulthood: cardiometabolic health of offspring conceived by assisted reproductive technologies, a systematic review.

Fertility and sterility·2026
Same journal

Uterus-Sparing Laparoscopic Reversal of Complete Non-Puerperal uterine Inversion: A rare Case and Challenging Procedure!

Fertility and sterility·2026
Same journal

Minimally Invasive, Fertility-Sparing Surgical Management of Multiple Bilateral Ovarian Dermoid Cysts.

Fertility and sterility·2026
Same journal

Preconception dietary patterns in association with live birth and pregnancy loss: a couples-based approach.

Fertility and sterility·2026
Same journal

Corrigendum to "Clinical management of mosaic results from preimplantation genetic testing for aneuploidy of blastocysts: a committee opinion" [Fertil Steril 2023;120:973-82].

Fertility and sterility·2026
See all related articles

New developments in transdermal estrogen (E2) therapy offer improved relief for menopausal symptoms and bone health. These advancements enhance quality of life and patient compliance for postmenopausal women.

Area of Science:

  • Endocrinology
  • Gynecology
  • Pharmacology

Background:

  • Menopause is associated with various symptoms and health concerns.
  • Estrogen replacement therapy (ERT) is a common treatment option.
  • Transdermal estrogen delivery offers an alternative to oral administration.

Purpose of the Study:

  • To review recent advancements in transdermal estrogen (E2) therapy.
  • To evaluate the efficacy and benefits of transdermal E2 in postmenopausal women.

Main Methods:

  • Bibliographic search of medical literature (Medline) from 1966-1995.
  • Identification of studies evaluating transdermal E2 in menopausal and postmenopausal women.

Main Results:

  • Transdermal E2 effectively alleviates menopausal symptoms, improves urogenital atrophy, and preserves bone density.

Related Experiment Videos

  • Studies indicate positive effects of transdermal E2 on cardiovascular function.
  • Improvements observed in quality of life, patient satisfaction, and compliance.
  • Emerging technologies include low-dose systems and 7-day patches for sustained E2 levels.

    • Conclusions:

    • Advancements in transdermal E2 administration show promise for increasing acceptance and adherence to long-term ERT.
    • Transdermal E2 offers a viable and effective option for managing postmenopausal symptoms and improving overall well-being.